Antidiabetic natural products: Roadmap 2024
Annual Reports in Medicinal Chemistry, ISSN: 0065-7743, Vol: 62, Page: 53-102
2024
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures8
- Readers8
Article Description
Diabetes mellitus is a chronic metabolic disorder marked by persistent hyperglycemia due to insulin insufficiency or resistance. This chapter delves into therapeutic strategies for managing diabetes, emphasizing natural anti-diabetic agents and their pharmacological mechanisms. We explore natural alternatives as inhibitors of glucose metabolism, including α-glucosidase inhibitors, DPP-IV inhibitors, diacylglycerol O-acyltransferase 1 and 2 inhibitors, fructokinase inhibitors, and fructose-1,6-bisphosphatase inhibitors. These agents significantly reduce postprandial hyperglycemia and enhance glucose homeostasis. The chapter also focuses on natural products promoting pancreatic beta-cell regeneration to restore endogenous insulin production; enhance glucose transport improving insulin sensitivity and facilitating glucose uptake. Ayurveda provides excellent natural strategies for managing diabetes using traditional remedies including single herbs, herbo-mineral formulations, medicated butters (Ghritas), oils (Taila), fermented syrups (Asava-aristas), and Guggulu (Commiphora mukul). Furthermore, the chapter reviews antidiabetics from other natural resources, including marine and microbial sources, detailing their unique bioactive compounds and therapeutic potential. The tradition-guided translation paradigm is highlighted as a novel approach for drug discovery, inspired by traditional knowledge. In conclusion, the chapter underscores the promising role of natural products in diabetes management, advocating for an integrative approach that merges traditional wisdom with contemporary research. This comprehensive overview aims to inform future studies and therapeutic developments, contributing to safer and more effective treatments for diabetes.
Bibliographic Details
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know